MARI — Marinomed Biotech AG Income Statement
0.000.00%
HealthcareBalancedMicro CapSucker Stock
- €56.06m
- €69.56m
- €11.63m
Annual income statement for Marinomed Biotech AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.81 | 4.67 | 6.14 | 8.12 | 11.6 |
Cost of Revenue | |||||
Gross Profit | 0.651 | -0.165 | -0.512 | -0.642 | 1.42 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.45 | 9.81 | 12.4 | 13.9 | 15.8 |
Operating Profit | -1.64 | -5.14 | -6.21 | -5.82 | -4.14 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.38 | -12.1 | -7.21 | -6.01 | -5.69 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.38 | -12.1 | -7.22 | -6.01 | -5.89 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.38 | -12.1 | -7.22 | -6.01 | -5.89 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.38 | -12.1 | -7.22 | -6.01 | -5.89 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.69 | -13.5 | -5.2 | -4.08 | -3.99 |
Dividends per Share |